Special Products becomes Veriton Pharma

Special Products becomes Veriton Pharma

October 3 2017 Special Products Ltd has changed its name to Veriton Pharma Limited, to better...

Quantum Pharmaceutical introduces new ordering system for Specials

Quantum Pharmaceutical introduces new ordering system for Specials

August 18 2017 Quantum Pharmaceutical is updating its ordering system for Specials medicines to...

Updated guidance for prescribing specials medicines published

Updated guidance for prescribing specials medicines published

June 15 2016 The Royal Pharmaceutical Society has published new guidance on prescribing specials...

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

May 31 2016 A drug recall for a batch of the specials product Epistatus (midazolam maleate)...

Drug Tariff updates include specials and unlicensed medicines price amendments

Drug Tariff updates include specials and unlicensed medicines price amendments

February 1 2016 The latest list of prices for specials and unlicensed medicines has been...

  • Special Products becomes Veriton Pharma

    Special Products becomes Veriton Pharma

    Tuesday, 03 October 2017 18:03
  • Quantum Pharmaceutical introduces new ordering system for Specials

    Quantum Pharmaceutical introduces new ordering system for Specials

    Friday, 18 August 2017 15:27
  • Updated guidance for prescribing specials medicines published

    Updated guidance for prescribing specials medicines published

    Wednesday, 15 June 2016 14:54
  • Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Drug alert issued for Epistatus Oromucosal Solution 10mg/ml

    Sunday, 05 June 2016 22:37
  • Drug Tariff updates include specials and unlicensed medicines price amendments

    Drug Tariff updates include specials and unlicensed medicines price amendments

    Monday, 01 February 2016 12:29

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pills2November 4 2015

The Royal Pharmaceutical Society is asking for comments on guidance it is updating for prescribers of the unlicensed medicines known as specials medicines.

Guidance for use in any care setting was initially issued in 2012 by the National Prescribing Centre and NICE for people prescribing specials. “At the request of NICE, we are updating and publishing the guidance on behalf of all the prescribing professions and are keen to ensure that prescribers, and their representative bodies and regulators, as well as patients have the opportunity to comment on the updated guidance,” said the RPS.

‘Prescribing Specials: Guidance for the prescribers of Specials’ is intended for use by all prescribers to help optimise treatment for patients for whom no suitable licensed medicine is available. Although it focuses on specials medicines, the principles it contains are considered “broadly applicable to the prescribing of other unlicensed medicines.”

The updated guidance has retained the basis of five key principles:

  • establish a clinical need
  • understand the patient’s experience and make a shared decision
  • identify medicines and preparations
  • monitor and review
  • ensure effective prescribing governance

In addition, the new draft includes a number of case studies which include key learning points illustrating the sorts of challenges that need to be met to ensure patients receive optimal treatment. Other updates reflect regulatory changes, changes in clinical practice and the changing NHS environment.

“The use of specials presents the NHS and patients with specific challenges, particularly when patients move between care settings. The importance of ensuring that patients and prescribers are aware of the complexities and risks associated with transferring the prescribing and supply of specials across settings is given more emphasis in this guidance,” says the draft document.

“Communication between prescribers and pharmacy colleagues also receives more emphasis encouraging pharmacists and prescribers to work together to ensure that patients are prescribed specials appropriately and supported adhere to their treatment.”

Later this month, the Royal Pharmaceutical Society is also expecting to publish updated guidance for pharmacists on the procurement and supply of specials.

Comments on the draft guidance for specials prescribing should be submitted to the RPS by December 14.

Links:

RPS announcement

RPS ‘Prescribing Specials: Guidance for the prescribers of Specials’ draft

Specials News

November 21 2017 Community pharmacy is campaigning today in Westminster, to promote the role that community pharmacies can play in helping people to stay healthy through the winter.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...